Timing of bone marrow transplantation in therapy of Hodgkin’s disease
Author:
Bierman Philip J.
Reference57 articles.
1. Aisenberg AC, Qazi R: Improved survival in Hodgkin’s disease. Cancer 37:2423–2429, 1976.
2. Bakemeier RF, Anderson JR, Costello W, et al.: BCVPP chemotherapy for advanced Hodgkin’s disease: evidence for greater duration of complete remission, greater survival, and less toxicity than with a MOPP regimen. Ann Intern Med 101:447–456, 1984.
3. Bonadonna G, Valagussa P, Santoro A: Alternating non-cross resistant combination chemotherapy or MOPP in stage IV Hodgkin’s disease. Ann Intern Med 104:739–746, 1986.
4. Longo DL, Young RC, Wesley M, et al.: Twenty years of MOPP therapy for Hodgkin’s disease. J Clin Oncol 4:1295–1306, 1986.
5. Santoro A, Bonadonna G, Valagussa P, et al.: Long-term results of combined chemotherapy-radiotherapy approach in Hodgkin’s disease: superiority of ABVD plus radiotherapy versus MOPP plus radiotherapy. J Clin Oncol 5:27–37, 1987.